VKH
ARNA

Virtu KCG Holdings’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Virtu KCG Holdings’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,430
Closed -$84K – 4243
2013
Q4 		$84K Buy
+1,430
New +$74.7K ﹤0.01% 3487

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Virtu KCG Holdings's ARNA Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2017, closing a stake of 19,403 shares — an estimated $283K sold.

Virtu KCG Holdings first reported a position in ARNA in Q3 2013 and held it in 13 quarters. The position peaked at $283K in Q1 2017. 102 funds tracked by Wall St. Rank hold ARNA as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Arena Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 19,403 Arena Pharmaceuticals Inc shares in Q2 2017, an estimated $283K.
  • Virtu KCG Holdings first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 13 quarters.
  • Virtu KCG Holdings's Arena Pharmaceuticals Inc position peaked at $283K in Q1 2017.
  • 102 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.